Talphera Stock Today
| TLPH Stock | 0.81 0.03 3.57% |
PerformanceWeakest
| Odds Of DistressRisky
|
Talphera is trading at 0.81 as of the 13th of February 2026. This is a 3.57% down since the beginning of the trading day. The stock's open price was 0.84. Talphera has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 15th of November 2025 and ending today, the 13th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of February 2011 | Category Healthcare | Classification Health Care |
Teliphone Corporation, a telecommunications company, offer voice, data, and cloud services in Canada. The company has 46.61 M outstanding shares of which 1.11 M shares are at this time shorted by private and institutional investors with about 3.47 trading days to cover. More on Talphera
Moving against Talphera Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Talphera Stock Highlights
| CEO Director | Vincent Angotti | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsDebt leverage enables Talphera to amplify potential investment gains using borrowed funds. Evaluating debt relative to total assets helps investors assess Talphera's financial structure and understand the extent to which Talphera's operations depend on creditor capital.
| |||||
Talphera (TLPH) is traded on NASDAQ Exchange in USA and employs 13 people. Talphera is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.88 M. Talphera conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 46.61 M outstanding shares of which 1.11 M shares are at this time shorted by private and institutional investors with about 3.47 trading days to cover.
Talphera currently holds about 90.29 K in cash with (12.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Talphera Probability Of Bankruptcy
Ownership AllocationTalphera shows a total of 46.61 Million outstanding shares. Talphera maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Talphera Ownership Details
Talphera Historical Income Statement
Talphera Stock Against Markets
Talphera Corporate Executives
Elected by the shareholders, the Talphera's board of directors comprises two types of representatives: Talphera inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Talphera. The board's role is to monitor Talphera's management team and ensure that shareholders' interests are well served. Talphera's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Talphera's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether Talphera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Talphera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Talphera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Talphera Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Talphera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more detail on how to invest in Talphera Stock please use our How to Invest in Talphera guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is there potential for Pharmaceuticals market expansion? Will Talphera introduce new products? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Talphera's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.